Filing Details

Accession Number:
0000950170-24-066175
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-29 20:11:32
Reporting Period:
2024-05-28
Accepted Time:
2024-05-29 20:11:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1579428 Axsome Therapeutics Inc. AXSM Pharmaceutical Preparations (2834) 454241907
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1658379 Mark Coleman C/O Axsome Therapeutics, Inc.
One World Trade Center, 22Nd Floor
New York NY 10007
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-05-28 5,249 $75.21 19,848 No 4 S Direct
Common Stock Disposition 2024-05-29 5,248 $75.14 14,600 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Such transaction was pursuant to a pre-approved 10b5-1 plan.
  2. Represents the sale of underlying shares of previously exercised stock options.
  3. Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $75.00 and $75.88.
  4. Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $75.00 and $75.90.